What are the three criteria of Whipple's triad used to confirm true hypoglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Whipple's Triad

Whipple's triad consists of three essential criteria that must all be present to confirm true hypoglycemia: (1) symptoms and/or signs consistent with hypoglycemia, (2) a documented low plasma glucose concentration, and (3) resolution of those symptoms after the plasma glucose is raised. 1, 2

The Three Components

1. Clinical Symptoms and Signs of Hypoglycemia

  • Autonomic/adrenergic symptoms include shakiness, tremors, sweating, palpitations, tachycardia, pallor, and hunger 3, 4
  • Neuroglycopenic symptoms include confusion, drowsiness, altered mental status, irritability, and headache—these result from direct cerebral glucose deprivation 3, 5
  • Symptoms typically begin when plasma glucose falls to approximately 70 mg/dL (3.9 mmol/L), which triggers neuroendocrine counterregulatory responses 3, 5
  • More severe neuroglycopenic symptoms appear at 54 mg/dL (3.0 mmol/L) when cerebral glucose delivery becomes insufficient for normal neuronal function 5

2. Low Plasma Glucose Concentration

  • A documented low glucose level must be measured during the symptomatic episode 4, 2
  • The diagnostic threshold is <70 mg/dL (<3.9 mmol/L) for the alert value 3, 4
  • Clinically significant hypoglycemia is defined as glucose <54 mg/dL (<3.0 mmol/L), representing Level 2 hypoglycemia where neuroglycopenic symptoms typically occur 3, 4
  • Blood glucose should be measured immediately when hypoglycemia is suspected; treatment should not be delayed awaiting laboratory confirmation if point-of-care testing shows values <70 mg/dL 6, 3

3. Resolution of Symptoms After Glucose Correction

  • Symptoms and signs must resolve after plasma glucose is raised to normal levels 1, 2
  • This confirms that the symptoms were indeed caused by hypoglycemia rather than another condition 7, 8
  • For conscious patients, administer 15-20 g of fast-acting carbohydrate (glucose preferred) and recheck glucose after 15 minutes 3, 4
  • If glucose remains low after 15 minutes, repeat carbohydrate administration 3, 4

Clinical Application

Why All Three Criteria Matter

  • All three components must be present to diagnose true hypoglycemia and avoid misdiagnosis 2
  • Symptoms alone are insufficient, as many conditions can mimic hypoglycemia without actual low glucose 7, 8
  • A low glucose reading without symptoms may represent laboratory error or physiologic variation 2
  • Failure of symptom resolution after glucose correction suggests an alternative diagnosis 8

Diagnostic Approach

  • Document Whipple's triad during a spontaneous symptomatic episode before pursuing extensive workup 4, 2
  • In patients without diabetes, obtain plasma insulin, C-peptide, proinsulin, beta-hydroxybutyrate, and screen for oral hypoglycemic agents during the hypoglycemic episode 4, 2
  • For predominantly postprandial symptoms, a mixed meal test is preferable to a 72-hour fast 8

Common Pitfalls to Avoid

  • Do not diagnose hypoglycemia without documenting all three components of Whipple's triad—this leads to unnecessary testing and misdiagnosis 2
  • Do not rely on patient-reported glucose values alone; confirm with simultaneous symptom documentation and response to treatment 7, 8
  • Do not dismiss glucose values between 54-70 mg/dL as insignificant; this Level 1 range still requires intervention and medication adjustment 3
  • Do not wait for laboratory confirmation before treating when point-of-care glucose is <70 mg/dL 6, 3

References

Guideline

Low Threshold for Hypoglycemia: Definition, Classification, and Acute Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Evaluation and Management of Non-Diabetic Hypoglycemia with Neuroglycopenic Symptoms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Physiological Thresholds and Counterregulatory Mechanisms in Hypoglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Approach to the patient with spontaneous hypoglycemia.

European journal of internal medicine, 2014

Related Questions

What is the appropriate workup for a patient with recurrent hypoglycemia?
What is the initial management and evaluation for a non-diabetic patient presenting with fasting hypoglycemia?
What are the diagnostic criteria for hypoglycemia (low blood sugar)?
What is the best course of action for a patient with non-fasting hypoglycemia (low blood sugar), normal lab results, and a history of past Epstein-Barr virus (EBV) infection?
What is the management plan for a patient in their 50s with asymptomatic hypoglycemia, normal C-peptide (connecting peptide), normal cortisol level, and normal insulin levels, including total and proinsulin levels?
What are the recommended alternative HIV‑1 regimens for switching from dolutegravir (DTG) due to contraindication, intolerance, or drug–drug interaction?
What does mild sacroiliac (SI) degenerative changes on a lumbar X‑ray indicate?
How should thymic squamous cell carcinoma be managed, including surgical resection, adjuvant radiotherapy and chemotherapy, and systemic therapy for unresectable or metastatic disease?
In a 76‑year‑old man with metastatic prostate cancer on androgen‑deprivation therapy receiving low‑dose abiraterone 250 mg once daily, should prednisolone be given 5 mg once daily or 10 mg daily (5 mg twice daily)?
In a post‑renal‑transplant patient with reduced renal function, can ciprofloxacin (Cipro) and metronidazole (Metro) be used together for infection coverage, and what are the appropriate dose adjustments and monitoring for tacrolimus or cyclosporine levels?
In a post‑transplant patient with acute gastroenteritis, should ciprofloxacin and metronidazole be given empirically?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.